Navigation Links
PharmaSmart International, Inc and AstraZeneca Canada Enter Into Strategic Partnership to Elevate Pharmacy Based Hypertension Management
Date:12/30/2009

PharmaSmart International, Inc., an award winning Inc. 5000 company and "Top 100" Rochester, NY Growth Company, is partnering with AstraZeneca Canada to deliver innovative tools and programs to pharmacists, physicians and patients for the improved management of hypertension. The partnership program positions community pharmacy at the front lines of disease state management, and will involve a select group of Canadian retail pharmacy participants.

Rochester, NY (PRWEB) December 30, 2009 -- PharmaSmart International, Inc., an award winning Inc. 5000 company and "Top 100" Rochester, NY Growth Company, is partnering with AstraZeneca Canada to deliver innovative tools and programs to pharmacists, physicians and patients for the improved management of hypertension. The partnership program positions community pharmacy at the front lines of disease state management, and will involve a select group of Canadian retail pharmacy participants. More details and timelines will be released at a later date.

“The AstraZeneca Canada partnership further strengthens our commitment to the retail pharmacy and the patient community, and aligns well with our mission and core competency,” states Ashton S. Maaraba, PharmaSmart’s Senior Vice President/GM, Global Sales & Operations. “Hypertension is the #1 contributor to premature death in North America. By combining our technology and programs with the strength and expertise of companies like AstraZeneca Canada, we can better combat this deadly disease. This program launch is the result of hard work by both the PharmaSmart and AstraZeneca Canada teams, as well as the vision and commitment of the select retail partners. Our shared vision and commitment made the partnership a reality.”

Josh Sarkis, PharmaSmart’s, Senior Vice President/GM, Strategic Business Development, stated, “It is now widely acknowledged that chronic diseases such as hypertension are best managed with the help of community based health professionals. By providing pharmacists with innovative technology, patient tools and educational support, we believe that we can help today’s pharmacy achieve its full potential in terms of managing the hypertensive patient. We are extremely pleased to be partnering with AstraZeneca Canada and our retail partners in a program that will accelerate this important evolution in pharmacy based healthcare.”

PharmaSmart, headquartered in Rochester, NY, USA, is a world leader in blood pressure screening technology, providing innovative solutions to meet the needs of medical providers, employers, pharmacists, and patients to test, track, and manage blood pressure. PharmaSmart equipment currently performs over 65 million blood pressure tests per year. PharmaSmart’s unique services, technology, and data integration capabilities are utilized by chain pharmacies, corporate worksites, fitness facilities, and medical clinics as a core disease state management solution.

For more information visit the company's website at www.pharma-smart.com or contact Corporate Communications Mary Ann Rutkowski at (800) 781-0323.

###

Read the full story at http://www.prweb.com/releases/PharmaSmart/AstraZeneca_Canada/prweb3392894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
2. PharmaSmart International Announces Integration with Microsoft HealthVault
3. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
4. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
5. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
6. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
7. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
8. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
9. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
10. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
11. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PharmaSmart International, Inc and AstraZeneca Canada Enter Into Strategic Partnership to Elevate Pharmacy Based Hypertension Management
(Date:5/4/2016)... WA (PRWEB) , ... May ... ... a full service insurance provider serving families of Camas and Vancouver, WA, ... current campaign fundraises for the National Breast Cancer Foundation and their Mammography ...
(Date:5/4/2016)... ... May 04, 2016 , ... The RIDER Institute announces an ... DRACO broad-spectrum antiviral therapeutics. DRACOs have proven effective against all 18 viruses tested ... at http://igg.me/at/EndTheVirus and runs for 60 days, we are raising new ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nike Rugby Camp's success is due in ... Willis, founder of Elite Rugby Camps and current Nike Camp director, has offered an ... 2009. , ā€œIā€™m excited for our eighth summer here in San Diego,ā€ says ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Dr. ... offering wisdom tooth removal surgery at their office. Wisdom tooth removal, a common dental ... not always problematic, they often are improperly erupted, resulting in risks of complications. By ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... DUBLIN , May 4, 2016 ... the "Global Cancer Stem Cell Therapy Market Outlook ... (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has ... therapeutics are expected to be developed in coming years. ... these techniques. Cancer stem cell therapies are also expected ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, ... contracted rheumatic fever, which damaged his heart. He continued ... But by June 2013, Shepherd,s heart was giving out ... death. On June 20, 2013, the Mesa, ... Artificial Heart (TAH-t). Like a heart transplant, the SynCardia ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: